MITCHELLS+BUT. LS-,085416/ GB00B1FP6H53 /
| 2024-05-15 1:04:28 PM | Chg. +0.060 | Volume | Bid1:04:28 PM | Ask1:04:28 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 2.960EUR | +2.07% | - Turnover: - |
2.960Bid Size: - | 3.000Ask Size: - | 1.64 bill.EUR | - | - |
GlobeNewswire
1:03 PM
Unicycive Therapeutics Presents Bioequivalence Data on Oxylanthanum Carbonate (OLC) at the National ...
GlobeNewswire
1:01 PM
Olema Oncology Announces Promising New Data for Palazestrant in Combination with Ribociclib Presente...
GlobeNewswire
1:00 PM
BiomX to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 21, 2024
GlobeNewswire
1:00 PM
Edible Garden Reports Significant 27.6% Year-Over-Year Revenue Growth for First Quarter of 2024
GlobeNewswire
1:00 PM
Dorman Products expands its catalog of cost-saving and aftermarket-exclusive repair solutions
GlobeNewswire
1:00 PM
Plug to Revolutionize Middle-Mile Delivery with Class 6 Fuel Cell Electric Truck Integration
GlobeNewswire
1:00 PM
Cabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
1:00 PM
Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Q1 2024 Results
GlobeNewswire
1:00 PM
Boralex announces a substantial 62% increase in net earnings and continued disciplined development o...
GlobeNewswire
1:00 PM
T2 Biosystems Announces $8 Million Private Placement Priced At-The-Market Under Nasdaq Rules
GlobeNewswire
1:00 PM
TFF Pharmaceuticals Provides Update on Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the ...
GlobeNewswire
1:00 PM
Creative Realities Inc. plans its expansion into EMEA and announces its beta launch to EMEA Integrat...
